Skip to main content
Clinical Trials/EUCTR2009-015523-91-AT
EUCTR2009-015523-91-ATActive, not recruitingPhase 1

Placebo controlled study on effects of vitamin D supplementation in healthy women and men on immunological, endocrine and metabolic parameters

Medizinische Universiätsklinik Graz, Abteilung für Endokrinologie und Nuklearmedizin0 sitesStarted: November 6, 2009Last updated:
Conditions
Drugs

Trial Snapshot

Phase
Phase 1
Status
Active, not recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional clinical trial of medicinal product

Eligibility Criteria

Sex
All

Inclusion Criteria

  • Informed consent
  • Healthy volunteers
  • Age of at least 18 years
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

Exclusion Criteria

  • Hypercalcemia (>2,65mmol/L)
  • Nursing women
  • Any disease that requires continuous treatment with medications
  • Intake of medication as part of another clinical trial

Investigators

Sponsor
Medizinische Universiätsklinik Graz, Abteilung für Endokrinologie und Nuklearmedizin

Similar Trials

Active, not recruiting
Not Applicable
Placebo controlled study on effects of vitamin D supplementation in type 1 diabetic subjects on immunological, endocrine and metabolic parameters: Step 2 of the Austrian Diabetes Prevention Programme (ADPP-002)To evaluate whether vitamin D supplementation in type 1 diabetic subjects significantly alters the proportion of regulatory T-cells of all circulating CD4 positive T-cells.
EUCTR2010-018901-12-ATMedical University Graz, Department of Internal Medicine, Div. Endocrinology and Metabolism
Active, not recruiting
Not Applicable
A randomized placebo controlled trial of vitamin D3 supplementation to a vulnerable patientsgroup susceptible to uppertract respiratory infections.Patients with primary or secondary immunodeficiencies and/or patients who have an increased incidence of airborn infections more than 42 infectionsday /year.
EUCTR2009-011758-16-SEKarolinska University Hospital Huddinge
Active, not recruiting
Phase 1
Prospective, placebo-controlled trial of vitamin D supplementation in patients with low-levels of 25-OH vitamin D to evaluate changes in markers of cardiovascular risk
EUCTR2007-007474-33-ATDr. Harald Dobnig, Medizinische Univ. Klinik Graz, Abteilung für Endokrinologie und Nuklearmedizin100
Not yet recruiting
Not Applicable
Vitamin D and Type 2 Diabetes Mellitus
CTRI/2022/10/046633niversity College of Medical Sciences ang GTB Hospital
Completed
Phase 3
Effect of supplementation in treatment of women with cervical intraepithelial neoplasia 2 and 3
IRCT201601045623N65Vice chancellor for research, Kashan University of Medical Sciences58